spacer
home > pmps > summer 2002 > liposomes as drug delivery systems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Liposomes as Drug Delivery Systems

The usefulness of liposomes in pharmacy and medicine as carriers of active substances has been postulated since the early 1960s, when the phenomenon of encapsulation of some chemical compounds in lipide microspheres was recognised. However, it was only in the past few years that the objective proof of therapeutic efficacy when using this method of drug delivery was realised and the first launches of liposomal drug dosage forms took place.

Basic Information on Liposomes

Liposomes are microscopic or submicroscopic structures of 10nm to 20mm in diameter. They are made up of one or many concentrically arranged lipid bilayers constituting an envelope. The basic matter of liposomes are amphiphilic compounds having clearly separated hydrophilic and hydrophobic centres. Hydrophilic components of lipides of bilayer are directed towards aqueous phases (external and internal), whereas hydrophobic components of both lipide layers are directed towards one another, forming the internal layer of a membrane.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Piotr Slifirski, Head of the Pharmaceutical Department
at the Pharmaceutical Research Institute in Poland Dr Piotr Slifirski is a Head of Pharmaceutical Department at the Pharmaceutical Research Institute in Warsaw, Poland.
Piotr studied Pharmacy at the Academy of Medicine in Warsaw. He holds a PhD in Pharmacy from the Academy of Medicine in Wroclaw, Poland, and specialises in drugs technology.

spacer
Dr Piotr Slifirski
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ROUSSELOT INTRODUCES X-PURE® GelMA FOR TRANSLATIONAL MEDICINE

Irving, United States [03 June 2020] — Rousselot, a Darling Ingredients brand and the global leader of collagen-based solutions, takes on the digital challenge and introduces X-Pure® GelMA at Bio Digital 2020. The first GMP-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications, X-Pure® GelMA is part of the X-Pure portfolio of ultra-pure gelatins and collagens, suitable for use as biomaterials in 3D bioprinting, tissue engineering, and regenerative medicine.
More info >>

White Papers

Role of Comparators in Clinical Trial Supply

Clinical Services International

CSI analyses the role of comparators in different trial designs and offers expert advice on robust methodology for choosing the most appropriate comparators. Case studies provide real insight on how to choose comparators for rare diseases and oncology studies.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement